Bank of Montreal’s veteran oil and gas analyst is making the case for a four-way mega merger in Western Canada’s Montney ...
BMO Capital Markets assumed coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to ...
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued ...
BMO Capital Markets initiated coverage on Dyne Therapeutics (DYN, Financials) with an Outperform rating and a $50 price target, suggesting a strong upside from the company's current share price of ...
Belski, chief investment strategist at BMO Capital Markets. The performance of technology (NYSEARCA:XLK) against the S&P 500 ...
BMO Capital upgraded Goeasy (EHMEF) to Outperform from Market Perform with a price target of C$200, down from C$207. Goeasy trades at trough multiples on tariff-scenario earnings, effectively ...
BMO Capital raised the firm’s price target on Okta (OKTA) to $130 from $105 and keeps a Market Perform rating on the shares. The firm had been ...
Bank stocks are sure to be long-term winners in Canada, but these three look ultra promising for investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results